Non-Pharmaceutical Interventions Sample Clauses

Non-Pharmaceutical Interventions. PHEP awardees should coordinate non-pharmaceutical interventions by developing and updating plans that include documentation of the applicable jurisdictional, legal, and regulatory authorities necessary for implementation in routing and incident-specific situations. Such plans must include necessary authorization for interventions with the following elements: individuals, groups, facilities, animals, food products, public works/utilities, and travel through ports of entry for state, local and territorial jurisdictions as appropriate. Plans should include consideration of the legal and planning issues for interventions such as isolation, quarantine, school and child care closures, workplace and community organization/event closure, and restrictions on movement. Activity 2: Ensure the Safety and Health of Responders Joint Requirements HPP and PHEP awardees, HCCs, and their members must equip, train, and provide resources necessary to protect responders, employees, and their families from hazards during response and recovery operations. Personal protective equipment (PPE), MCMs, workplace violence training, psychological first aid training, and other interventions specific to an emergency are all necessary to protect responders and health care workers from illness or injury and should be readily available to the health care workforce.
Sample 1Sample 2Sample 3See All (4)
AutoNDA by SimpleDocs
Non-Pharmaceutical Interventions. Introduction The Non-pharmaceutical Interventions (NPI) capability refers to the ability of health departments, in coordination with their partners, to recommend or implement non-drug and non-vaccine-based containment, mitigation or decontamination strategies in order to prevent or control disease, injuries, and exposures. NPIs are designed both to save lives and to alleviate the surge of individuals placing demands on the healthcare system during an emergency. The NPI pre-incident planning measure gauges the ability of health departments to identify and collaborate with partners to define roles for the development and implementation of NPIs and to identify factors that affect NPI implementation (e.g., legal barriers or intended and unintended consequences). The NPI response measure assesses a health department’s ability to bring key partners to the table to develop and/or implement an NPI at the time of an incident. Capability Functions This capability consists of the ability to perform the following functions:
Sample 1Sample 2
Non-Pharmaceutical Interventions. Introduction <.. image(Quarantine Sign Public Domain Image 1327 from xxxx://xxxx.xxx.xxx) removed ..> The Non-Pharmaceutical Interventions (NPI) capability refers to the ability of health departments, in coordination with their partners, to recommend or implement non-drug and non-vaccine-based containment, mitigation or decontamination strategies in order to prevent or control disease, injuries, and exposures. NPIs are designed both to save lives and to alleviate the surge of individuals placing demands on the healthcare system during an emergency. The NPI pre-incident process measure gauges the ability of health departments to identify and collaborate with partners to define roles for the development and implementation of NPIs and to identify factors that affect NPI implementation (e.g., legal barriers, intended and unintended consequences). The NPI response measure assesses a health department’s ability to bring key partners to the table to develop and/or implement an NPI at the time of an incident. Capability Functions This capability consists of the ability to perform the following functions:
Sample 1Sample 2
Non-Pharmaceutical Interventions. 5. Medical Countermeasure Dispensing For a complete list of all 15 public health preparedness capabilities, visit xxxxx://xxx.xxx.xxx/cpr/readiness/capabilities.htm. KEY CHALLENGE KEY STRENGTH Medical Countermeasure Readiness: Ensuring that medicine and supplies get to those who need them most during an emergency. Well-established and frequently utilized emergency operations systems Recruitment and training of points of dispensing staff States, territories, and localities are required to develop emergency plans covering children, pregnant women, and other vulnerable populations. Population 2017 Households included children 32% Respondents who know they are pregnant 3% Respondents 65 or older 15% Respondents who reported having diabetes 8% Respondents who reported a condition that limits activities — Respondents who reported a health problem that required the use of specialized equipment — PHEP funds support staff who have expertise in many different areas. PHEP-Funded Staff 2017 CDC Field Staff 3 Educators 2 Epidemiologists 2 Health Professionals — Laboratorians — Other Staff 22 PHEP PROGRAM–KEY PERFORMANCE MEASURE RESULTS 2017 2016 2015 Emergency Operations Coordination In an emergency, it is critical that staff can meet quickly to plan for, lead, and manage a public health response. Public health staff serve as Incident Commanders, Public Information Officers, Planning Section Chiefs, Operations Section Chiefs, and other response roles. Number of minutes for public health staff with incident management lead roles to report for immediate duty N/A 52 780 Timely and effective communication between lab and epidemiologic public health emergency. Public Health Laboratory Testing staff can reduce death and injuries in a 2017 Results of communication drills between laboratory and epidemiological staff completed within 45 minutes Drill 1: Completed drill, but not in time Drill 2: Completed drill in time Laboratory Response Network biological (LRN-B) and PulseNet labs rapidly identify and notify CDC of potential biological health threats to minimize disease outbreaks. CDC manages the LRN-B, a group of public health labs with testing capabilities to detect and confirm biological health threats. CDC also manages PulseNet, a national network of labs that analyzes and connects foodborne illness cases together to identify outbreak sources. Current number of LRN-B public health labs: 1 Public Health Laboratory Testing: LRN-B 2015 2016 2017 Proportion of LRN-B proficienc...
Sample 1
Non-Pharmaceutical Interventions. It is the awardee’s responsibility to determine which entity or entities is responsible for completing a performance element. This can refer to the awardee central office, its regional or district offices, local health departments, etc. All entities responsible for completion of a given performance element must have completed the performance element in order to answer “Yes” to Question 2, above. Example #1 (decentralized state). In this state, there are 10 autonomous LHDs (or autonomous regions/districts, etc.) in the jurisdiction, but only 5 have been funded to complete a given performance element for this measure. For the awardee to enter “Yes” on Question 2 for that performance element, the 5 funded LHDs (not 10) must have completed it. If the awardee itself was responsible for completion of a different performance element, it could only enter “Yes” on Question 2 for its performance element once it has been completed by the awardee. Example #2 (centralized state with 8 regional or district offices). In this state, the awardee has determined that the main office and 4 of its 8 regional offices will be responsible for addressing all the performance elements for this measure in this budget period. The awardee will determine when it and these 4 regional offices have satisfactorily completed the performance element. Core Public Pre-Incident Once the main office and the 4 regional offices have done so, the awardee may enter “Yes” on Question 2 for those performance elements. If, in this example, the awardee main office is the only entity responsible for completing a performance element (i.e., it does not assign any responsibility to any of its regions), then it may enter “Yes” once it (the main office) has completed the performance element. Response Example #3 (Directly funded city). In this example, the directly funded city is the only entity responsible for all the performance elements for this measure. Therefore it will be able to enter “Yes” to Question 2 for each of the performance elements as it completes them. Non-Pharmaceutical Interventions PHEP 11.3: Develop NPI Recommendations with Partners‌‌ Proportion of key partners identified to have an incident-specific role that participated in the development or implementation of NPI during an incident Measure Applies To: Circumstances for Reporting: Data May Be Taken From: Other Considerations: ☑ States □ Annual Reporting ☑ Incident □ Optional ☑ Directly Funded Localities □ If PHEP Funds Allocated to the Ca...
Sample 1
Non-Pharmaceutical Interventions. Develop and implement protocols for rapid and appropriate public health actions, such as controlled movement, isolation, quarantine, or public health orders. Plans should include: • Alternate travel plans for individuals subject to controlled movement who are not allowed to travel by long-distance commercial conveyances, such as aircraft, ship, bus, or train; how jurisdictions will ensure permitted travel is conducted by noncommercial conveyances. • Whether federal public health travel restrictions (Do Not Board) will be used to enforce controlled movement. • Whether specific community locations will be designated for safe housing of persons subject to restricted movement and the role of public health orders and corresponding compensation and support to be provided to individuals under a public health order. • The role of public health in coordinating with healthcare facilities and jurisdictional authorities to ensure the separation (through isolation or quarantine) of an individual or group who is reasonably believed to be infected with Ebola from those who are not infected to prevent the possible spread to others who have not been exposed. • Work with CDC’s Division of Global Migration and Quarantine (DGMQ) to screen travelers in their states who have entered the United States via cleared flights, broken itineraries, or land border crossing and have not undergone enhanced screening at one of the five airports conducting enhanced entry screening of travelers from Ebola-affected countries. Awardees will be required to conduct an initial Check and Report Ebola (CARE) screening with such travelers over the telephone, in person, or to designate appropriate public health outreach workers in local jurisdictions. • Support ongoing communication between the jurisdiction and its CDC quarantine station as applicable regarding coordination with identified hospitals that would support jurisdictional response to a communicable disease. For further information, see Interim U.S. Guidance for Monitoring and Movement of Persons with Potential Ebola Virus Exposure, including the application of movement restrictions when indicated. • Coordinate appropriate environmental cleaning and waste management in community settings (other than healthcare settings) where PUIs or those with probable or confirmed Ebola virus infections have been located.
Sample 1
Non-Pharmaceutical Interventions. Work for this capability will be addressed in future contract years.
Sample 1
AutoNDA by SimpleDocs
Non-Pharmaceutical Interventions. PHEP 11.1 Determine Role with Partners (Awardee)
Sample 1
Non-Pharmaceutical Interventions 
Sample 1Sample 2Sample 3

Related to Non-Pharmaceutical Interventions

  • Third Party Technology Customer is hereby notified that third parties have licensed certain technology to Company, which is contained in the Software. Notwithstanding anything herein to the contrary, Customer hereby consents to the disclosure of Customer’s identity, and such other terms of this Agreement as necessary, to such third party licensors for the purpose of enabling Company to comply with the terms and conditions of such third party licenses. Any such Customer information will be provided pursuant to an obligation of confidentiality and nondisclosure at least as stringent as that imposed by this Agreement.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • Licensed Technology The term “Licensed Technology” shall mean the Licensed Patent Rights, Licensed Know-How and Licensed Biological Materials.

  • TECHNOLOGY/KNOWLEDGE TRANSFER ACTIVITIES The goal of this task is to develop a plan to make the knowledge gained, experimental results, and lessons learned available to the public and key decision makers. The Recipient shall: • Prepare an Initial Fact Sheet at start of the project that describes the project. Use the format provided by the CAM. • Prepare a Final Project Fact Sheet at the project’s conclusion that discusses results. Use the format provided by the CAM. • Prepare a Technology/Knowledge Transfer Plan that includes: o An explanation of how the knowledge gained from the project will be made available to the public, including the targeted market sector and potential outreach to end users, utilities, regulatory agencies, and others.

  • Product Technical Support & Maintenance Licensee shall have the option of electing the Product technical support and maintenance (“maintenance”) set forth in the Contract by giving written notice to Contractor any time during the Centralized Contract term. Maintenance term(s) and any renewal(s) thereof are independent of the expiration of the Centralized Contract term and will not automatically renew. Maintenance shall include, at a minimum, (i) the provision of error corrections, updates, revisions, fixes, upgrade and new releases to Licensee, and (ii) Help Desk assistance with locally accessible “800” or toll free, local telephone service, or alternatively on-line Help Desk accessibility. Contractor shall maintain the Products so as to provide Licensee with the ability to utilize the Products in accordance with the Product documentation without significant functional downtime to its ongoing business operations during the maintenance term. Authorized User shall not be required to purchase maintenance for use of Product, and may discontinue maintenance at the end of any current maintenance term upon notice to Contractor. In the event that Authorized User does not initially acquire or discontinues maintenance of licensed Product, it may, at any time thereafter, reinstate maintenance for Product without any additional penalties or other charges, by paying Contractor the amount which would have been due under the Contract for the period of time that such maintenance had lapsed, at then current NYS net maintenance rates.

  • Background Technology List here prior contracts to assign Inventions that are now in existence between any other person or entity and you. [ ] List here previous Inventions which you desire to have specifically excluded from the operation of this Agreement. Continue on reverse side if necessary.

  • Clinical 2.1 Provides comprehensive evidence based nursing care to patients including assessment, intervention and evaluation.

  • Influenza Vaccine Upon recommendation of the Medical Officer of Health, all employees shall be required, on an annual basis to be vaccinated and or to take antiviral medication for influenza. If the costs of such medication are not covered by some other sources, the Employer will pay the cost for such medication. If the employee fails to take the required medication, she may be placed on an unpaid leave of absence during any influenza outbreak in the home until such time as the employee has been cleared by the public health or the Employer to return to the work environment. The only exception to this would be employees for whom taking the medication will result in the employee being physically ill to the extent that she cannot attend work. Upon written direction from the employee’s physician of such medical condition in consultation with the Employer’s physician, (if requested), the employee will be permitted to access their sick bank, if any, during any outbreak period. If there is a dispute between the physicians, the employee will be placed on unpaid leave. If the employee gets sick as a reaction to the drug and applies for WSIB the Employer will not oppose the application. If an employee is pregnant and her physician believes the pregnancy could be in jeopardy as a result of the influenza inoculation and/or the antiviral medication she shall be eligible for sick leave in circumstances where she is not allowed to attend at work as a result of an outbreak. This clause shall be interpreted in a manner consistent with the Ontario Human Rights Code.

  • Diagnostic procedures to aid the Provider in determining required dental treatment.

Time is Money Join Law Insider Premium to draft better contracts faster.